Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1467581
PUBLISHER: IMARC | PRODUCT CODE: 1467581
Point of Care Molecular Diagnostics Market Report by Product and Service, Technology, Application, End User, and Region 2024-2032
PUBLISHED:
PAGES: 136 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global point of care molecular diagnostics market size reached US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032.
Point-of-care (POC) molecular diagnostics refer to tests performed by physicians to diagnose and detect infectious diseases. It includes hematology, pregnancy, fertility, infectious diseases, urinalysis testing kits, and cardiometabolic and glucose monitoring devices. POC molecular diagnostics is widely used for identifying infectious agents, minimal residual disease, and gastrointestinal disorders, monitoring hemoglobin and fecal occult blood, and determining a patient's ability to metabolize a drug or drug class. These tests offer faster results, reduce complications associated with mistreatment, and improve infection control measures. As a result, POC molecular diagnostics finds extensive applications in hospitals, intensive care units (ICUs), research institutes, clinics, decentralized laboratories, and homecare facilities.
Point of Care Molecular Diagnostics Market Trends:
The increasing prevalence of infectious diseases across the globe is creating a positive outlook for the market. POC molecular diagnostic tests is a cost-effective solution widely used to manage infectious diseases, such as flu, tuberculosis, human immunodeficiency virus (HIV) infection, chlamydia, and hepatitis. Additionally, the rising demand for PCR test kits to effectively manage and control the spread of COVID-19 is acting as another growth-inducing factor. Furthermore, the adoption of miniaturization, nanotechnology, and microfluidics to develop low-cost, user-friendly, and highly sensitive molecular diagnostic tests is providing an impetus to the market growth. Moreover, the implementation of various government initiatives toward improving healthcare infrastructure and enhancing molecular diagnostic capabilities is positively influencing the market growth. Other factors, including rapid advancements in deoxyribonucleic acid (DNA) sequencing, rising awareness regarding advanced therapeutic and diagnostic tests, increasing geriatric population, and recent developments in cloud-connected POC diagnostic technologies, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global point of care molecular diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and service, technology, application and end user.
Breakup by Product and Service:
Assays and Kits
Instruments and Analyzers
Software and Services
Breakup by Technology:
Polymerase Chain Reaction (PCR)
Hybridization
DNA sequencing
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others
Breakup by Application:
Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Others
Breakup by End User:
Physicians' Offices
Hospitals and ICUs
Research Institutes
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Binx Health Inc., Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd, Gene STAT Molecular Diagnostics LLC, Hemocue AB (Danaher Corporation), Meridian Bioscience Inc., Molbio Diagnostics Private Limited, Quidel Corporation, Siemens Healthcare GmbH (Siemens AG), Thermo Fisher Scientific Inc. and Visby Medical Inc.
Key Questions Answered in This Report
- 1. What was the size of the global point of care molecular diagnostics market in 2023?
- 2. What is the expected growth rate of the global point of care molecular diagnostics market during 2024-2032?
- 3. What are the key factors driving the global point of care molecular diagnostics market?
- 4. What has been the impact of COVID-19 on the global point of care molecular diagnostics market?
- 5. What is the breakup of the global point of care molecular diagnostics market based on the product and service?
- 6. What is the breakup of the global point of care molecular diagnostics market based on the technology?
- 7. What is the breakup of the global point of care molecular diagnostics market based on application?
- 8. What are the key regions in the global point of care molecular diagnostics market?
- 9. Who are the key players/companies in the global point of care molecular diagnostics market?
Product Code: SR112024A6271
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Point of Care Molecular Diagnostics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product and Service
- 6.1 Assays and kits
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Instruments and Analyzers
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Polymerase Chain Reaction (PCR)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Hybridization
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 DNA sequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Microarray
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Application
- 8.1 Infectious Diseases
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Oncology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Hematology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Prenatal Testing
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Endocrinology
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by End User
- 9.1 Physicians' Offices
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Hospitals and ICUs
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Research Institutes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Becton Dickinson and Company
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Binx Health Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 Co-Diagnostics Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.5 F. Hoffmann-La Roche Ltd
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.6 Gene STAT Molecular Diagnostics LLC
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Hemocue AB (Danaher Corporation)
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Meridian Bioscience Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Molbio Diagnostics Private Limited
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Quidel Corporation
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Siemens Healthcare GmbH (Siemens AG)
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.12 Thermo Fisher Scientific Inc.
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.13 Visby Medical Inc.
- 15.3.13.1 Company Overview
- 15.3.13.2 Product Portfolio
- 15.3.1 Abbott Laboratories
Product Code: SR112024A6271
List of Figures
- Figure 1: Global: Point of Care Molecular Diagnostics Market: Major Drivers and Challenges
- Figure 2: Global: Point of Care Molecular Diagnostics Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Point of Care Molecular Diagnostics Market: Breakup by Product and Service (in %), 2023
- Figure 5: Global: Point of Care Molecular Diagnostics Market: Breakup by Technology (in %), 2023
- Figure 6: Global: Point of Care Molecular Diagnostics Market: Breakup by Application (in %), 2023
- Figure 7: Global: Point of Care Molecular Diagnostics Market: Breakup by End User (in %), 2023
- Figure 8: Global: Point of Care Molecular Diagnostics Market: Breakup by Region (in %), 2023
- Figure 9: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Point of Care Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Point of Care Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Point of Care Molecular Diagnostics (Hybridization) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Point of Care Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Point of Care Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Point of Care Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Point of Care Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Point of Care Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Point of Care Molecular Diagnostics (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Point of Care Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Point of Care Molecular Diagnostics (Hematology) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Point of Care Molecular Diagnostics (Hematology) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Global: Point of Care Molecular Diagnostics (Endocrinology) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Global: Point of Care Molecular Diagnostics (Endocrinology) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: Global: Point of Care Molecular Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: Global: Point of Care Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Global: Point of Care Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Global: Point of Care Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Global: Point of Care Molecular Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Global: Point of Care Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: North America: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: North America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: United States: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: United States: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Canada: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Canada: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: Asia-Pacific: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: Asia-Pacific: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: China: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: China: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Japan: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Japan: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: India: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: India: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: South Korea: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: South Korea: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Australia: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Australia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: Indonesia: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: Indonesia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: Europe: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: Europe: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Germany: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Germany: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: France: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: France: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: United Kingdom: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: United Kingdom: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Italy: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: Italy: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Spain: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: Spain: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: Russia: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 82: Russia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 83: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 84: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 85: Latin America: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 86: Latin America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 87: Brazil: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 88: Brazil: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 89: Mexico: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 90: Mexico: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 91: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 92: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 93: Middle East and Africa: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 94: Middle East and Africa: Point of Care Molecular Diagnostics Market: Breakup by Country (in %), 2023
- Figure 95: Middle East and Africa: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 96: Global: Point of Care Molecular Diagnostics Industry: SWOT Analysis
- Figure 97: Global: Point of Care Molecular Diagnostics Industry: Value Chain Analysis
- Figure 98: Global: Point of Care Molecular Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Point of Care Molecular Diagnostics Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Product and Service (in Million US$), 2024-2032
- Table 3: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
- Table 4: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 5: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 6: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: Global: Point of Care Molecular Diagnostics Market: Competitive Structure
- Table 8: Global: Point of Care Molecular Diagnostics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.